In the US, Cotellic (cobimetinib systemic) is a member of the drug class multikinase inhibitors and is used to treat Melanoma, Metastatic.
Ingredient matches for Cotellic
Cobimetinib hemifumarate (a derivative of Cobimetinib) is reported as an ingredient of Cotellic in the following countries:
- United Kingdom
- United States
← International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.